Rejuvenate Bio Inc
Rejuvenate Bio uses a gene therapy approach to treat chronic, age-related diseases by targeting the root causes of aging to create treatments for chronic conditions affecting both companion animals and humans.
Funding history
About Rejuvenate Bio Inc
How much funding has Rejuvenate Bio Inc raised?
Rejuvenate Bio Inc has raised $19.5M in total funding. The most recent round was Series A.
Where is Rejuvenate Bio Inc headquartered?
Rejuvenate Bio Inc is headquartered in San Diego, CA.
What does Rejuvenate Bio Inc do?
Rejuvenate Bio uses a gene therapy approach to treat chronic, age-related diseases by targeting the root causes of aging to create treatments for chronic conditions affecting both companion animals and humans.
What problem does Rejuvenate Bio Inc solve?
Chronic, age-related diseases such as osteoarthritis, heart disease, and cancer are described as the primary threat to longevity and quality of life in aging dogs, and the page notes six in ten Americans live with at least one chronic disease, a leading cause of death, disability, and healthcare cost.
What's Rejuvenate Bio Inc's solution?
Rejuvenate Bio develops gene therapies aimed at the root causes of aging to treat chronic conditions in both companion animals and humans.
What makes Rejuvenate Bio Inc different?
The company is running trials in dogs (MVD Trial 2020 and MVD Trial 2026) as part of its approach, using naturally aging companion animals as part of its pipeline toward human treatments.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
